Newton Centre, MA, United States of America

Maria Isabel Chiu

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 11.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2009-2025

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: Maria Isabel Chiu: Pioneering Innovations in Monoclonal Antibodies

Introduction

Maria Isabel Chiu is a prominent inventor based in Newton Centre, MA, whose groundbreaking work has led to the filing of 10 patents. Her inventions primarily focus on the development of monoclonal antibodies, a pivotal area in therapeutic treatments.

Latest Patents

Among her latest patents, Maria has disclosed innovative anti-GDF-15 antibodies. These monoclonal antibodies are designed to bind and inhibit the activity of human GDF15. They present potential treatment options for individuals experiencing body weight loss, including cachexia, which is often associated with the over-expression of this specific protein.

Career Highlights

Throughout her career, Maria has made significant contributions in the biotechnology field while working with companies such as Aveo Pharmaceuticals, Inc. and Pd-1 Acquisition Group, LLC. Her expertise and dedication have been crucial in advancing therapeutic solutions in the healthcare sector.

Collaborations

In her journey as an inventor, Maria has collaborated with talented professionals, including Lorena Lerner and Sandra Abbott. These partnerships have fostered a supportive network that has enhanced her innovative pursuits and contributed to the success of her projects.

Conclusion

Maria Isabel Chiu exemplifies the spirit of innovation in the realm of biotechnology. With her significant number of patents and contributions to the field of monoclonal antibodies, she continues to inspire aspiring inventors and researchers worldwide. Her ongoing work promises to have a lasting impact on treatments for conditions linked to GDF15.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…